In the present study, based on our previous findings of CXCR4 in trastuzumab resistance, we investigated the therapeutic potential of targeting CXCR4 in trastuzumab-resistant breast cancer models and explored the associated mechanisms. This evidence concerns the gene CXCR4 and breast cancer.